BCG Research Directory · Fall 2026

Sources

Every figure and citation on this site is drawn from this directory: peer-reviewed publications extracted from PubMed datasets, with the authors behind each paper.

View source spreadsheet
1,000
Author Records
100
Unique Authors
165
Publications
92
Journals
2006–2026
Years Covered

Research Directory

100 researchers and writers, listed by full name with the work that informs us.

Alex Bertelli
Founder & CEO · HAVEN Lock / Forbes Business Council Member
Military-Grade Security Engineering, Special Ops Aviation
HAVEN Lock M&A & Case Analysis
Alistair Johnson, PhD
Data Scientist · Health Data Nexus / PhysioNet
Open Health Datasets, Biomedical Data Curation
Bridge2AI-Voice Dataset & Health Data Nexus
Andrew Rittler
Head of Business Development · Yeji X
Value-Based Care Execution, Healthcare ACO Partnerships
Yeji X Value-Based Care Platform
Bill Braniff
Executive Director · Polarization & Extremism Research Lab (PERIL), American University
Public Health Approaches to Extremism, Attitudinal Inoculation
Applying the Public Health Model to Democracy
Brian Dailey
Former CTO / Advisor · Stratasan / DNA Partners
Enterprise Healthcare Data Architecture, HIPAA Compliance Systems
Enterprise Healthtech Acceleration Case Analysis
Carrie Nall
Former SVP Finance / Fractional CFO · Stratasan / DNA Partners
Predictive Cash-Flow Modeling, Fiscal Clarity Defense
Enterprise Healthtech Acceleration Case Analysis
Clay Banks
Founder & CEO / EiR · InPaceline / TakeOff Accelerator (Nashville Entrepreneur Center)
AI Startup Operating Systems, HAVEN Lock Hardware M&A Exit, GloriLight
Strategic Analysis of Serial Entrepreneurship & InPaceline OS
Constance A. Mitchell
Scientific Program Director · Health and Environmental Sciences Institute (HESI)
Botanical Safety Assessment, Phytochemical Characterization
A Multi-Detector Analytical Approach for Complex Botanical Extracts
David Jung
CEO & Founder · Yeji X / Former CEO, Promedius
Multimodal AI Prediction Engines, Value-Based Care Interventions
Yeji X Value-Based Care Platform
David Malone
Co-Founder & EiR · Confirmation (acquired for $500M) / Project FinTech
Fintech Scaling, Global Financial Solutions
Nashville Entrepreneur Center Leadership Profile
Dr. Alexandros Sigaras
Co-Investigator & Lead Engineer · Weill Cornell Medicine
Healthcare Software Architecture, Mobile Voice Acquisition Engines
Bridge2AI-Voice Application Feasibility Study
Dr. Anaïs Rameau, MD
Co-Investigator & Laryngologist · Weill Cornell Medicine
Voice AI Analytics, Acoustic Dysphonia Diagnostics
Bridge2AI-Voice Pediatric Dataset v1.1.0
Alfeel AH.

Therapeutic Applications of Natural Products in Biomedicine and Pharmacotherapy

Life (Basel)2026PMID 42355401 DOI
Ranjay Kumar Choudhary

Therapeutic Applications of Natural Products in Biomedicine and Pharmacotherapy

Life (Basel)2026PMID 42355401 DOI
Ashwani Bhardwaj

Therapeutic Applications of Natural Products in Biomedicine and Pharmacotherapy

Life (Basel)2026PMID 42355401 DOI
Shagun Agarwal

Therapeutic Applications of Natural Products in Biomedicine and Pharmacotherapy

Life (Basel)2026PMID 42355401 DOI
Rabab H Elshaikh

Therapeutic Applications of Natural Products in Biomedicine and Pharmacotherapy

Life (Basel)2026PMID 42355401 DOI
Abdulkhakov Ikhtiyor Umarovich

Therapeutic Applications of Natural Products in Biomedicine and Pharmacotherapy

Life (Basel)2026PMID 42355401 DOI
Rakhi Mishra

Therapeutic Applications of Natural Products in Biomedicine and Pharmacotherapy

Life (Basel)2026PMID 42355401 DOI
Prem Shankar Mishra

Therapeutic Applications of Natural Products in Biomedicine and Pharmacotherapy

Life (Basel)2026PMID 42355401 DOI
Rahul Kumar

Therapeutic Applications of Natural Products in Biomedicine and Pharmacotherapy

Life (Basel)2026PMID 42355401 DOI
Sakshi Patel

Therapeutic Applications of Natural Products in Biomedicine and Pharmacotherapy

Life (Basel)2026PMID 42355401 DOI
Ashok Kumar SahFirst author

Therapeutic Applications of Natural Products in Biomedicine and Pharmacotherapy

Life (Basel)2026PMID 42355401 DOI
Xing Z.

Chinese Herbal Medicines for Diabetic Cardio-Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms

J Nutr Metab2026PMID 41743998 DOI
Xinyu Yang

Chinese Herbal Medicines for Diabetic Cardio-Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms

J Nutr Metab2026PMID 41743998 DOI
Wei Liu

Chinese Herbal Medicines for Diabetic Cardio-Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms

J Nutr Metab2026PMID 41743998 DOI
Cuicui Cheng

Chinese Herbal Medicines for Diabetic Cardio-Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms

J Nutr Metab2026PMID 41743998 DOI
Wei Li

Chinese Herbal Medicines for Diabetic Cardio-Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms

J Nutr Metab2026PMID 41743998 DOI
Shuwen Luo

Chinese Herbal Medicines for Diabetic Cardio-Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms

J Nutr Metab2026PMID 41743998 DOI
Ying SuFirst author

Chinese Herbal Medicines for Diabetic Cardio-Cerebrovascular Diseases: Key Bioactive Metabolites and Action Mechanisms

J Nutr Metab2026PMID 41743998 DOI
Syed K.First author

Four Decades of Cytochrome P450 Research in Africa: A Historical Overview of Scientific Contributions, Research Trends, ...

Biology (Basel)2026PMID 42589110 DOI
Jayasri MA.

Advancing personalized medicine for Parkinson's disease: transforming treatment and therapeutic outcomes

3 Biotech2026PMID 41815828 DOI
K Suthindhiran

Advancing personalized medicine for Parkinson's disease: transforming treatment and therapeutic outcomes

3 Biotech2026PMID 41815828 DOI
Andhere Animish

Advancing personalized medicine for Parkinson's disease: transforming treatment and therapeutic outcomes

3 Biotech2026PMID 41815828 DOI
Sai Sankeerthana Bedadakota

Advancing personalized medicine for Parkinson's disease: transforming treatment and therapeutic outcomes

3 Biotech2026PMID 41815828 DOI
M SwathiFirst author

Advancing personalized medicine for Parkinson's disease: transforming treatment and therapeutic outcomes

3 Biotech2026PMID 41815828 DOI
Winther K.First author

The Clinical Implications of Ashwagandha (Withania somnifera L.) with a Special Reference to Side Effects-A Review

Nutrients2026PMID 41830041 DOI
✦ BEN CAO GANG · Est. 2026
These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease.